Pubblicazioni ufficiali MedinCell S.A.

Azioni

Tempo reale Euronext Paris Altri mercati azionari 09:26:44 26/04/2024			Variaz. 5gg	Var. 1 gen.
12,72 ^EUR	+2,58%		+14,59%	+76,67%

16/04	Medincell stipula un accordo strategico di co-sviluppo e licenza con AbbVie per sviluppare terapie iniettabili a lunga durata d'azione di nuova generazione	CI
09/04	Medincell riceve una sovvenzione di estensione di 6 milioni di dollari da Unitaid per la sperimentazione del farmaco contro la malaria	MT

Changes in management and corporate officers	13/03	CO
Changes in management and corporate officers	13/03	CO
Half-year report	22/12	CO
1st-half-year results	19/12	CO
1st-half-year results	19/12	CO
Monthly statement on voting rights	31/10/23	CO
Monthly statement on voting rights	30/09/23	CO
Minutes of the general assembly	12/09/23	CO
Minutes of the general assembly	12/09/23	CO
Combined general shareholders meeting	04/08/23	CO
Annual ESG Report	28/07/23	CO
Universal registration document	28/07/23	CO
Universal registration document	28/07/23	CO
Monthly statement on voting rights	30/06/23	CO
Annual results	26/06/23	CO
Annual results	26/06/23	CO
Monthly statement on voting rights	31/05/23	CO
Threshold crossings	23/05/23	CO
Corporate officers' Statement : Sale	04/05/23	CO
Monthly statement on voting rights	30/04/23	CO
Monthly statement on voting rights	31/03/23	CO
Threshold crossings	15/03/23	CO
Monthly statement on voting rights	28/02/23	CO
Monthly statement on voting rights	31/01/23	CO
Monthly statement on voting rights	31/12/22	CO